xista science ventures focuses on investing in visionary science start-ups and science-driven companies built on deep research, particularly academic spin-offs and deep tech startups with solid innovation in human health and industrial technologies. Their strategy involves providing seed and follow-on funding, along with comprehensive support in areas like finance, intellectual property, and business development, to help translate scientific advances into commercial ventures.
40% of their portfolio is in Biotech & Life Sciences. They made 4 investments in the last 12 months. Their most common stage is series-a (60% of deals). Average disclosed round size is $9.9M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$100M
Top Stage
Series A
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
Top Co-Investors
Last updated: 12 April 2026